Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

AML - 858

Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

Vaishnavi Rao

Poster Presenter: Vaishnavi Rao

Thumbnail for Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

AML - 867

Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

Arashdeep Singh

Poster Presenter: Arashdeep Singh

Previous 1...42 43 44 45 46 47 48...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

AML - 872

Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

Jacob Herstein

Poster Presenter: Jacob Herstein

Thumbnail for Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

AML - 897

Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

Eiline Cai

Poster Presenter: Eiline Cai

Thumbnail for Effect of Nonselective ί-Blocker Use on Postallogeneic Stem Cell Transplant Outcomes in Patients with Myeloid Neoplasms: A Trinetx-Based Retrospective Cohort Study

AML - 898

Effect of Nonselective ί-Blocker Use on Postallogeneic Stem Cell Transplant Outcomes in Patients with Myeloid Neoplasms: A Trinetx-Based Retrospective Cohort Study

Madhu Bhargavi Chandra

Poster Presenter: Madhu Bhargavi Chandra

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

AML - 917

Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

Harsha Pattnaik

Poster Presenter: Harsha Pattnaik

Thumbnail for Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

AML - 920

Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

Cesar Copaja-Corzo

Poster Presenter: Cesar Copaja-Corzo

$Thumbnail for Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis$

AML - 923

Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis

Bhaswanth Bollu

Poster Presenter: Bhaswanth Bollu

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors